NYSE · Healthcare
Birchtech Corp. (BCHT)
As-reported financials and recent SEC filings for Birchtech Corp., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$17.6M
Net income
$-3.0M
Net margin
-17.2%
Diluted EPS
$-0.16
ROE
176.5%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $17.6M | $17.4M | $17.6M | $21.6M | $13.0M |
| Gross profit | $7.4M | $7.1M | $5.5M | $7.0M | $5.1M |
| Operating income | $-3.0M | $-7.2M | $-9.0M | $903,987 | — |
| Net income | $-3.0M | $-10.8M | $5.7M | $-1.6M | $-3.6M |
| Diluted EPS | $-0.16 | $-0.57 | $0.30 | $-0.10 | — |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
ARS2026-06-24
View on EDGAR →DEF 14A2026-06-24
View on EDGAR →PRE 14A2026-06-08
View on EDGAR →10-Q2026-05-13
View on EDGAR →8-K/A2026-05-12
View on EDGAR →8-K2026-05-06
View on EDGAR →32026-05-06
View on EDGAR →8-K2026-04-13
View on EDGAR →Largest Healthcare peers
Go deeper on BCHT
Search Birchtech Corp.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.